Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 7, 2003, Pages 853-860

  Cui, X G ^a   Tashiro, Katsumi ^a   Matsumoto, H ^a   Tsubokawa, Y ^a   Kobayashi, T ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acute respiratory distress syndrome; Aspiration pneumonitis; Dextran; Inhalation; Pulmonary surfactant; Rats

Indexed keywords

D 1662; DEXTRAN; LUNG SURFACTANT; PANCURONIUM BROMIDE; PENTOBARBITAL;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; MALE; MILK; NONHUMAN; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS; TREATMENT OUTCOME;

AEROSOLS; ANALYSIS OF VARIANCE; ANIMALS; ANTICOAGULANTS; DEXTRANS; DISEASE MODELS, ANIMAL; INHALATION EXPOSURE; MALE; MILK; OXYGEN; PULMONARY SURFACTANTS; RATS; RATS, WISTAR; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 0042849007     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.00168.x     Document Type: Article

References (29)

1. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
2. Luhr OR, Antonsen K, Karlsson M et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 1999; 159: 1849-61.
3. Gregory TJ, Longmore WJ, Moxley MA et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-81.
4. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982; 70: 673-83.
5. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993; 328: 861-8.
6. Gregory TJ, Steinberg KP, Spragg R et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 1309-15.
7. Tashiro K, Yamada K, Li WZ, Matsumoto Y, Kobayashi T. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats. Crit Care Med 1996; 24: 488-94.
8. Lewis J, Ikegami M, Higuchi R, Jobe A, Absolom D. Nebulized vs. instilled exogenous surfactant in an adult lung injury model. J Appl Physiol 1991; 71: 1270-6.
9. Kobayashi T, Ohta K, Tashiro K et al. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol 1999; 86: 1778-84.
10. Taeusch HW, Lu KW, Goerke J, Clements JA. Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 1999; 159: 1391-5.
11. Nitta K, Kobayashi T. Impairment of surfactant activity and ventilation by proteins in lung edema fluid. Respir Physiol 1994; 95: 43-51.
12. Robertson B, Curstedt T, Grossmann G, Kobayashi T, Kokubo M, Suzuki Y. Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant. Eur J Pediatr 1988; 147: 168-73.
13. Li WZ, Chen WM, Kobayashi T. Aerosolized surfactant reverses respiratory failure in lung-lavaged rats. Acta Anaesthesiol Scand 1994; 38: 82-8.
14. Nishina K, Mikawa K, Takao Y, Maekawa N, Obara H. Effects of exogenous surfactant on acute lung injury induced by intratracheal instillation of infant formula or human breast milk in rabbits. Anesthesiology 1999; 91: 240-52.
15. Knight PR, Rutter T, Tait AR, Coleman E, Johnson K. Pathogenesis of gastric particulate lung injury: a comparison and interaction with acidic pneumonitis. Anesth Analg 1993; 77: 754-60.
16. Enhörning G, Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics 1972; 50: 58-66.
17. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43: 198-203.
18. Tashiro K, Kobayashi T, Robertson B. Dextran reduces surfactant inhibition by meconium. Acta Paediatr 2000; 89: 1439-45.
19. Spragg RG, Gilliard N, Richman P et al. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994; 105: 195-202.
20. Walmrath D, Günther A, Ghofrani HA et al. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996; 154: 57-62.
21. Holm BA, Notter RH, Finkelstein JN. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 1985; 38: 287-98.
22. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987; 62: 429-37.
23. Holm BA, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988; 49: 49-55.
24. Chen W, Kobayashi T, Li W et al. Side effects of surfactant replacement: comparison of intratracheal instillation and nebulizing administration in normal rats. Hokuriku J Anesthesia 1992; 26: 21-8.
25. Schermuly R, Schmehl T, Günther A, Grimminger F, Seeger W, Walmrath D. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange. Am J Respir Crit Care Med 1997; 156: 445-53.
26. Schermuly RT, Günther A, Weissmann N et al. Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (V̇A/Q̇) mismatch in a model of acute lung injury. Am J Respir Crit Care Med 2000; 161: 152-9.
27. Calkovska A, Sun B, Curstedt T, Renheim G, Robertson B. Combined effects of high-frequency ventilation and surfactant treatment in experimental meconium aspiration syndrome. Acta Anaesthesiol Scand 1999; 43: 135-45.
28. II, Carney DE et al. Altered alveolar mechanics in the acutely injured lung. Crit Care Med 2001; 29: 1049-55.
29. Tashiro K, Yamada K, Konzaki T et al. Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats. Br J Anaesth 2001; 87: 266-71.